Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Vaccination | Research

Measles outbreak in Western Uganda: a case-control study

Authors: Abel Wilson Walekhwa, Moses Ntaro, Peter Chris Kawungezi, Chiara Achangwa, Rabbison Muhindo, Emmanuel Baguma, Michael Matte, Richard Migisha, Raquel Reyes, Peyton Thompson, Ross M. Boyce, Edgar M. Mulogo

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

Measles outbreaks are prevalent throughout sub-Saharan Africa despite the preventive measures like vaccination that target under five-year-old children and health systems strengthening efforts like prioritizing the supply chain for supplies. Measles immunization coverage for Kasese district and Bugoye HC III in 2018 was 72 and 69%, respectively. This coverage has been very low and always marked red in the Red categorization (below the national target/poor performing) on the national league table indicators. The aim of this study was to assess the scope of the 2018–2019 measles outbreak and the associated risk factors among children aged 0–60 months in Bugoye sub-county, Kasese district, western Uganda.

Methods

We conducted a retrospective unmatched case-control study among children aged 0–60 months with measles (cases) who had either a clinical presentation or a laboratory confirmation (IgM positivity) presenting at Bugoye Health Centre III (BHC) or in the surrounding communities between December 2018 and October 2019.. Caregivers of the controls (whose children did not have measles) were selected at the time of data collection in July 2020. A modified CDC case investigation form was used in data collection. Quantitative data was collected and analyzed using Microsoft excel and STATA version 13. The children’s immunization cards and health registers at BHC were reviewed to ascertain the immunization status of the children before the outbreak.

Results

An extended measles outbreak occurred in Bugoye, Uganda occured between December 2018 and October 2019. All 34 facility-based measles cases were documented to have had maculopapular rash, conjunctivitis, and cough. Also, the majority had fever (97%), coryza (94.1%), lymphadenopathy (76.5%), arthralgias (73.5%) and Koplik Spots (91.2%) as documented in the clinical registers. Similar symptoms were reported among 36 community-based cases. Getting infected even after immunized, low measles vaccination coverage were identified as the principal risk factors for this outbreak.

Conclusion

Measles is still a significant problem. This study showed that this outbreak was associated with under-vaccination. Implementing a second routine dose of measles-rubella vaccine would not only increase the number of children with at least one dose but also boost the immunity of those who had the first dose.
Appendix
Available only for authorised users
Literature
3.
go back to reference Control CfD, Prevention: national notifiable diseases surveillance system (NNDSS). Morbidity and Mortality Weekly Report Data available at https://data.cdc.gov/. Accessed 20 Oct 2020. Control CfD, Prevention: national notifiable diseases surveillance system (NNDSS). Morbidity and Mortality Weekly Report Data available at https://​data.​cdc.​gov/​. Accessed 20 Oct 2020.
5.
go back to reference Mahase E. Measles cases rise 300% globally in first few months of 2019. BMJ. 2019;365. Mahase E. Measles cases rise 300% globally in first few months of 2019. BMJ. 2019;365.
7.
go back to reference WHO: More than 140,000 die from measles as cases surge worldwide. 2019. WHO: More than 140,000 die from measles as cases surge worldwide. 2019.
10.
go back to reference Monitor D. 30 people hospitalised following measles outbreak; 2019. Monitor D. 30 people hospitalised following measles outbreak; 2019.
11.
go back to reference Organization WH: Weekly bulletin on outbreak and other emergencies: week 27: 30 June-06 July 2018. 2018. Organization WH: Weekly bulletin on outbreak and other emergencies: week 27: 30 June-06 July 2018. 2018.
12.
go back to reference Uganda Ministry of Health. National Guidelines for the Management of Common Conditions. Kampala: Ministry of Health Uganda; 2016. Uganda Ministry of Health. National Guidelines for the Management of Common Conditions. Kampala: Ministry of Health Uganda; 2016.
13.
go back to reference WHO. Measles vaccines: WHO position paper - April 2017. Weekly Epidemiol Record. 2017;92(17):205–8. WHO. Measles vaccines: WHO position paper - April 2017. Weekly Epidemiol Record. 2017;92(17):205–8.
14.
go back to reference Melenotte C, Cassir N, Tessonnier L, Brouqui P. Atypical measles syndrome in adults: still around. BMJ Case Rep. 2015;2015:bcr2015211054. Melenotte C, Cassir N, Tessonnier L, Brouqui P. Atypical measles syndrome in adults: still around. BMJ Case Rep. 2015;2015:bcr2015211054.
16.
go back to reference HMIS. Quarterly disease surveillance report in. Kampala: Ministry of Health; 2019. HMIS. Quarterly disease surveillance report in. Kampala: Ministry of Health; 2019.
17.
go back to reference Uganda Bureau of Statistics 2016, The National Population and Housing Census 2014 – Main Report, Kampala, Uganda. Uganda Bureau of Statistics 2016, The National Population and Housing Census 2014 – Main Report, Kampala, Uganda.
18.
go back to reference UNEPI: Immunization guidelines by UNEPI. 2019. UNEPI: Immunization guidelines by UNEPI. 2019.
21.
go back to reference Scotti R, Piredda I, Murgia I, Ganga A, Giadrossich F. The open data kit suite, Mobile data collection technology as an op-portunity for forest mensuration practices. Ann Silvicultural Res. 2020;44(2):86–94. Scotti R, Piredda I, Murgia I, Ganga A, Giadrossich F. The open data kit suite, Mobile data collection technology as an op-portunity for forest mensuration practices. Ann Silvicultural Res. 2020;44(2):86–94.
23.
go back to reference Arie S. Congo sees rise in deaths from malaria, measles, and cholera as Ebola outbreak swallows up resources: British medical journal publishing Group; 2019. Arie S. Congo sees rise in deaths from malaria, measles, and cholera as Ebola outbreak swallows up resources: British medical journal publishing Group; 2019.
24.
go back to reference Tusiime PK, Ssendagire MS, Ario AR, Kadobera MD, Eyu MP, Aceng FL, et al. Ministry of health Uganda. Epidemiol Bull. 2017;2(5). Tusiime PK, Ssendagire MS, Ario AR, Kadobera MD, Eyu MP, Aceng FL, et al. Ministry of health Uganda. Epidemiol Bull. 2017;2(5).
25.
go back to reference Mafigiri R, Nsubuga F, Ario AR. Risk factors for measles death: Kyegegwa District, western Uganda, February–September, 2015. BMC Infect Dis. 2017;17(1):1–7.CrossRef Mafigiri R, Nsubuga F, Ario AR. Risk factors for measles death: Kyegegwa District, western Uganda, February–September, 2015. BMC Infect Dis. 2017;17(1):1–7.CrossRef
26.
go back to reference Biribawa C, Atuhairwe JA, Bulage L, Okethwangu DO, Kwesiga B, Ario AR, et al. Measles outbreak amplified in a pediatric ward: Lyantonde District, Uganda, august 2017. BMC Infect Dis. 2020;20:1–8.CrossRef Biribawa C, Atuhairwe JA, Bulage L, Okethwangu DO, Kwesiga B, Ario AR, et al. Measles outbreak amplified in a pediatric ward: Lyantonde District, Uganda, august 2017. BMC Infect Dis. 2020;20:1–8.CrossRef
29.
go back to reference Moss W. Measles in vaccinated individuals and the future of measles elimination: Oxford University Press US; 2018. Moss W. Measles in vaccinated individuals and the future of measles elimination: Oxford University Press US; 2018.
30.
go back to reference Vono M, Eberhardt CS, Auderset F, Mastelic-Gavillet B, Lemeille S, Christensen D, et al. Maternal antibodies inhibit neonatal and infant responses to vaccination by shaping the early-life B cell repertoire within germinal centers. Cell Rep. 2019;28(7):1773–84 e1775. Vono M, Eberhardt CS, Auderset F, Mastelic-Gavillet B, Lemeille S, Christensen D, et al. Maternal antibodies inhibit neonatal and infant responses to vaccination by shaping the early-life B cell repertoire within germinal centers. Cell Rep. 2019;28(7):1773–84 e1775.
32.
go back to reference Bagenda F, Mulogo EM, Apecu RO, Kisakye A, Opar BT. Rubella IgM epidemiology in the pre-rubella vaccination era in Uganda. BMC Infect Dis. 2020;20(1):1–7.CrossRef Bagenda F, Mulogo EM, Apecu RO, Kisakye A, Opar BT. Rubella IgM epidemiology in the pre-rubella vaccination era in Uganda. BMC Infect Dis. 2020;20(1):1–7.CrossRef
Metadata
Title
Measles outbreak in Western Uganda: a case-control study
Authors
Abel Wilson Walekhwa
Moses Ntaro
Peter Chris Kawungezi
Chiara Achangwa
Rabbison Muhindo
Emmanuel Baguma
Michael Matte
Richard Migisha
Raquel Reyes
Peyton Thompson
Ross M. Boyce
Edgar M. Mulogo
Publication date
01-12-2021
Publisher
BioMed Central
Keyword
Vaccination
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-06213-5

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.